Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
Jonas Elias Schweig(James A. Haley Veterans' Hospital), Daniel Paris(Swiss Tropical and Public Health Institute), Michael Mullan(Roskamp Institute), Hailan Yao(Capital Institute of Pediatrics), Fiona Crawford(James A. Haley Veterans' Hospital), Benoit Mouzon(United States Department of Veterans Affairs), David Beaulieu‐Abdelahad(Roskamp Institute), Ghania Ait‐Ghezala(Roskamp Institute)
Cited by 47
Related Papers
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay
|Clinical Microbiology and Infection|2020|549
Critical role of TRPC6 channels in the formation of excitatory synapses
|Nature Neuroscience|2008|219
Essential Role of TRPC6 Channels in G2/M Phase Transition and Development of Human Glioma
|JNCI Journal of the National Cancer Institute|2010|174
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
|Journal of Neuroinflammation|2010|165
<i>MiR‐125b</i> targets BCL3 and suppresses ovarian cancer proliferation
|International Journal of Cancer|2010|143